# US 2013/0253476 A1 · Bladder drug eluting device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0253476 A1
- Document ID: US20130253476A1
- Status: Published application
- Kind: A1
- Application number: 13/741,918
- Filed: 2013-01-15
- Published: 2013-09-26
- Earliest claimed: 2012-03-21
- Assignees: AMS Research Corporation
- Applicants: Ams Research Corporation
- Inventors: Brian P. Watschke
- Web page: https://patentgrep.com/patent/US20130253476A1

## CPC

- A61M 31/002: {Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time (artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50)}
- A61M 25/10: Balloon catheters ({A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02;} inflatable balloons for placing stents or stent-grafts A61F2/958 {; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00})
- A61M 29/00: Dilators with or without means for introducing media, e.g. remedies
- A61M 29/02: Dilators made of swellable material {(balloon catheters for angioplasty A61M25/104)}
- A61M 2025/105: {having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes}
- A61M 2025/1054: {having detachable or disposable balloons}
- A61M 2210/1085: Bladder
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A drug delivery system that can be deployed from a catheter and retained within the bladder for delivery of treatment drug solutions over a period of time. The delivery system includes an inflatable or expandable delivery element that can be collapsed within the catheter tip for navigation into the bladder before being inflated or expanded within the bladder. The inflated or expanded delivery element can engage the bladder walls or sized to be too large to be passed from the bladder such that the delivery element is retained within the bladder after inflation or expansion to administer a treatment drug solution over an extended period of time.

## Claims

### Claim 1

A drug delivery device for treating bladder disorders, comprising:
a first catheter having a lumen defined between a proximal end and a distal tip; and
a delivery element having a first non-expanded state and a second expanded state,
wherein the delivery element is fully contained within the lumen as the distal tip is navigated into a bladder; and
wherein the delivery element transitions to the second expanded state when the delivery element is advanced out of the lumen such that the delivery element contacts an internal bladder wall to deliver a treatment drug from the delivery element to the bladder.

### Claim 2 (depends on 1)

The drug delivery device of claim 1, wherein the delivery element comprises a flexible ring, wherein the flexible ring assumes a folded state in the first non-expanded state and assumes a ring shape when in the expanded state.

### Claim 3 (depends on 2)

The drug delivery device of claim 2, wherein the flexible ring comprises a drug eluting flexible ring such that the treatment drug is delivered to the bladder through contact of the drug eluting flexible ring with the internal bladder wall.

### Claim 4 (depends on 2)

The drug delivery device of claim 2, wherein the flexible ring allows passage of urine through a center portion of the ring such that the flexible ring can remain in the expanded state within the bladder without impacting bladder function.

### Claim 5 (depends on 1)

The drug delivery device of claim 1, wherein the delivery element comprises a first inflation balloon, and wherein the first inflation balloon assumes an uninflated state in the first non-expanded state and assumes an inflated state in the second expanded state.

### Claim 6 (depends on 5)

The drug delivery device of claim 5, wherein an exterior balloon wall is in contact with the internal bladder wall when the inflation balloon is in the second expanded state.

### Claim 7 (depends on 6)

The drug delivery device of claim 6, wherein the inflation balloon is inflated with an inflation fluid to assume the second expanded state.

### Claim 8 (depends on 7)

The drug delivery device of claim 7, wherein the inflation fluid comprises the treatment drug.

### Claim 9 (depends on 5)

The drug delivery device of claim 5, wherein the first inflation balloon comprises a semi-permeable membrane.

### Claim 10 (depends on 5)

The drug delivery device of claim 5, wherein the first inflation balloon comprises a plurality of orifices formed in a balloon wall.

### Claim 11 (depends on 10)

The drug delivery device of claim 10, wherein a pressurized inflation fluid is forced through the plurality of orifices, the pressurized inflation fluid including the treatment drug.

### Claim 12 (depends on 1)

The drug delivery device of claim 1, wherein the treatment drug is introduced into the delivery element with a jet injection system.

### Claim 13

A method for delivering a bladder treatment drug, comprising:
providing a first catheter having a lumen defined between a proximal end and a distal tip, the first catheter including a delivery element within the lumen;
advancing the delivery element out of the lumen such that the delivery element assumes an expanded disposition within a bladder, wherein the delivery element is in contact with an internal bladder wall; and
delivering a bladder treatment drug to the internal bladder wall through contact of the delivery element with the internal bladder wall.

### Claim 14 (depends on 13)

The method of claim 13, wherein the delivery element comprises a foldable ring.

### Claim 15 (depends on 14)

The method of claim 14, further comprising:
depositing the foldable ring within the bladder such that the foldable ring remains in contact with the internal bladder wall following removal of the first catheter.

### Claim 16 (depends on 15)

The method of claim 15, further comprising:
allowing urine to pass through a center portion of the foldable ring such that urinary function is maintained following removal of the first catheter.

### Claim 17 (depends on 16)

The method of claim 16, further comprising:
eluting the treatment drug from the flexible ring to the internal bladder wall through continued contact of the flexible ring with the internal bladder wall following removal of the first catheter.

### Claim 18 (depends on 13)

The method of claim 13, wherein the delivery element comprises a first inflation balloon, and where the method further comprises:
inflating the first inflation balloon with an inflation fluid such that the first inflation balloon is in contact with the internal bladder wall.

### Claim 19 (depends on 18)

The method of claim 18, wherein the inflation fluid comprises the bladder treatment drug and wherein the method further comprises:
pressurizing the inflation fluid such that the inflation fluid is directed through a plurality of orifices in a balloon wall such that the bladder treatment drug is delivered to the internal bladder wall.

### Claim 20 (depends on 19)

The method of claim 19, further comprising:
separating the first inflation balloon from the first catheter such that first inflation balloon remains in contact with the internal bladder wall following removal of the first catheter.

### Claim 21 (depends on 13)

The method of claim 13, further comprising:
injecting the bladder treatment drug into the delivery element with a jet injection system.
